UK markets closed
NIKKEI 225
38,460.08 +907.92 (+2.42%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.72 -0.64 (-0.77%) GOLD FUTURES
2,341.90 -0.20 (-0.01%) DOW
38,427.16 -76.53 (-0.20%) Bitcoin GBP
52,072.32 -1,499.40 (-2.80%)
Kintara Therapeutics, Inc. (KTRA)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:22PM EDT. Market open.
| Previous close | 0.1327 |
| Open | 0.1306 |
| Bid | 0.1347 x 400 |
| Ask | 0.1382 x 400 |
| Day's range | 0.1299 - 0.1429 |
| 52-week range | 0.0810 - 5.9800 |
| Volume | |
| Avg. volume | 14,088,714 |
| Market cap | 5.329M |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA
Kintara (KTRA) inks a definitive merger agreement with TuHURA for an all-stock transaction. It is expected to close in the third quarter of 2024. The stock surges 63.4%.
- Zacks
Kintara (KTRA) Rises 41% on $2M Grant for Breast Cancer Therapy
Kintara (KTRA) receives a $2 million grant from the National Institutes of Health to develop its breast cancer treatment candidate, REM-001. The stock surges 41%.
© 2024 Yahoo. All rights reserved.